Aquestive Therapeutics, Inc. (AQST)
NASDAQ: AQST · Real-Time Price · USD
6.59
-0.10 (-1.49%)
Oct 10, 2025, 3:01 PM EDT - Market open
Aquestive Therapeutics Market Cap
Aquestive Therapeutics has a market cap or net worth of $797.22 million as of October 10, 2025. Its market cap has increased by 73.71% in one year.
Market Cap
797.22M
Enterprise Value
774.52M
1-Year Change
73.71%
Ranking
Category
Stock Price
$6.59
Market Cap Chart
Since July 25, 2018, Aquestive Therapeutics's market cap has increased from $393.23M to $797.22M, an increase of 102.74%. That is a compound annual growth rate of 10.29%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Oct 9, 2025 | 809.31M | 149.33% |
| Dec 31, 2024 | 324.59M | 140.67% |
| Dec 29, 2023 | 134.87M | 176.07% |
| Dec 30, 2022 | 48.85M | -68.73% |
| Dec 31, 2021 | 156.24M | -13.14% |
| Dec 31, 2020 | 179.87M | -3.55% |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Jul 25, 2018 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 759.23B |
| Johnson & Johnson | 456.84B |
| AbbVie | 408.50B |
| UnitedHealth Group | 335.03B |
| AstraZeneca | 266.28B |
| Novo Nordisk | 265.74B |
| Novartis AG | 257.26B |
| Abbott Laboratories | 233.69B |